Vitalijs Skrivelis is Chairman of the Supervisory Board of the Latvian Association of Chemical and Pharmaceutical Industry (LAKIFA) and Member of Management board and co-owner PharmIdea LLC, Latvia, both since 2008, and Member of the Management Board of the Pharma and Chemistry Competence Centre of Latvia since 2011.Previously Vitalijs Skrivelis was Director of Grindeks PharmaChemi, an Active Pharmaceutical Ingredient Business unit of JSC GRINDEKS (2001-2008 ); Vice-Director for Production and General Manager at GRINDEKS (1993-2000); and a researcher at the Institute of Molecular Biology of the Latvian Academy of Sciences (theme “Anti-hepatitis B antibodies in human organism”, 1985-1992).
His major professional achievements include:
- Turn-around of JSC Grindeks chemical business from stagnating performance into growing, profitable, FDA (USA) accepted international active ingredient business with 65 customers in 40 countries and 8 million EUR turnover in 2007.
- Establishing Pharmidea LLC in 2008, the only sterile technology research lab and EU Good Manufacturing Practice certified sterile manufacturing pilot-plant in Latvia after re-gaining independance in 1991, and joining the EU in 2004. Investment scope 4,5 million EUR. PharmIdea sterile product competences are powered by isolator technology and aseptic freeze drying capabilities.
- Boosting industrial innovation in Latvia via active lobbying and creation of the Competence Centre programme in collaboration with the Ministry of Economics and the Latvian Investment and Development Agency. 6 Competences centres, serving main exporting industries of Latvia, were launched in May 2011.
Vitalijs Skrivelis has an MS in Biochemistry, which he received from the Faculty of Biology, University of Latvia, in 1985, and a Master of Business Administration degree from the Riga Business School (2002, thesis “Turnaround strategy of JSC Grindeks chemical business”).